PROF SEC Filings: 8-K, 10-Q, S-3 & 424B – Profound Medical

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

NEWProfound Medical to Participate in the Stifel 2026 Healthcare Conference

Nov 9, 2026

8-K

Profound Medical Reports Q3 2026 Results, Expands Distribution, and Announces Leadership Changes

Nov 5, 2026

8-K

Profound Medical and Cook Medical Partner to Expand U.S. TULSA-PRO Sales Channels

Nov 3, 2026

8-K

Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar Hosted by Profound Medical

Oct 22, 2026

8-K

Profound Medical Highlights New TULSA-PRO Clinical Evidence and Platform Expansion at the 15th Interventional MRI Symposium

Oct 14, 2026

8-K

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

Oct 9, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Dec 22, 2025

Registrations

TYPE

HEADLINE

FILED AT

S-3

SHARE RESALE REGISTRATION

May 12, 2026

S-3

November 2025 SHELF

Nov 13, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 12, 2024

F-10/A

SHARE RESALE REGISTRATION | Offering amount: $150,000,000.00 EFFECTIVE

Jul 10, 2024

F-10

SHARE RESALE REGISTRATION | Offering amount: $150,000,000.00 EFFECTIVE

Jun 14, 2024

F-10/A

SHELF | Offering amount: $100,000,000.00 EFFECTIVE

Mar 23, 2022

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

S-3

Form S-3 - Registration statement under Securities Act of 1933

May 12, 2026

S-3

Form S-3 - Registration statement under Securities Act of 1933

Nov 13, 2025

Menawat Arun Swarup (Reporting)

May 20, 2025

SCHEDULE 13G/A

GAGNON SECURITIES LLC (Filed by)

Jan 23, 2025

SC 13G/A

GAGNON SECURITIES LLC (Filed by)

Nov 14, 2024

144

Form 144 - Report of proposed sale of securities

Nov 12, 2024

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

May 20, 2026

CORRESP

Form CORRESP - Correspondence

May 15, 2026

LETTER

Form UPLOAD - SEC-generated letter

May 15, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Dec 5, 2025

CORRESP

Form CORRESP - Correspondence

Dec 2, 2025

SUPPL

Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]

Dec 6, 2024

Profound Medical Corp. PROF · SEC Filings